Rosenblatt Recitals at Home in aid of Target Ovarian Cancer
Rosenblatt Recitals has brought together 30 of the greatest voices in opera performing arias and duets under eight themed programmes. The singers, all former Rosenblatt Recitalists, perform the music that they love, from the intimate setting of their homes, many during the harshest of Covid-19 lockdown restrictions.
The concerts are available as video and audio streaming click here for £30 for the full season pass (or £5 per programme) and in audio only click here for £24.99 (£ 3.99per programme). All proceeds from Rosenblatt Recitals at Home are being donated to Target Ovarian Charity (UK registered charity no. 6619981), the leading cancer charity fighting ovarian cancer on all fronts.
With special thanks to Serena Gamberoni and Simon Weir of Classical Media for their invaluable help in putting these programmes together.
“Rosenblatt Recitals at Home aims to bring some much-needed sunshine from artists’ homes to those of music lovers around the world. The majority of singers had to film and record themselves and all were socially distanced; at the outset, we didn’t really know what to expect. The result is beyond anything I could have wished for and a wonderful celebration of the voice on the 20th anniversary of Rosenblatt Recitals. I do hope that the eight programmes will raise everyone’s spirits as well as provide much needed funds for this amazing charity, Target Ovarian Cancer.”
Ian Rosenblatt OBE
Founder of Rosenblatt Recitals
“Singers shouldn’t be silent and nor must we about this devastating disease. This special edition of Rosenblatt Recitals is a world-class initiative and we are thrilled that the proceeds will benefit women with ovarian cancer, now and in the future. One in 50 women will receive an ovarian cancer diagnosis - we desperately need funds to ensure that everyone knows the symptoms, receives an early diagnosis and the very best treatment, and that we fund research to help save lives. The pandemic has hit hard, and the work of Target Ovarian Cancer has never been more needed.”
Annwen Jones OBE
Chief Executive, Target Ovarian Cancer